HK1049157A1 - 具有螺接的三環化合物 - Google Patents

具有螺接的三環化合物

Info

Publication number
HK1049157A1
HK1049157A1 HK03100716.0A HK03100716A HK1049157A1 HK 1049157 A1 HK1049157 A1 HK 1049157A1 HK 03100716 A HK03100716 A HK 03100716A HK 1049157 A1 HK1049157 A1 HK 1049157A1
Authority
HK
Hong Kong
Prior art keywords
spiro union
tricyclic compounds
useful
relates
inhibitor
Prior art date
Application number
HK03100716.0A
Other languages
English (en)
Inventor
西田英光
齊藤文彥
原田晃輔
白水郁也
Original Assignee
持田制藥株式會社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 持田制藥株式會社 filed Critical 持田制藥株式會社
Publication of HK1049157A1 publication Critical patent/HK1049157A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96444—Factor X (3.4.21.6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Prostheses (AREA)
  • External Artificial Organs (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK03100716.0A 1999-06-30 2003-01-28 具有螺接的三環化合物 HK1049157A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22288399 1999-06-30
PCT/JP2000/004374 WO2001002397A1 (fr) 1999-06-30 2000-06-30 Composes tricycliques presentant une jonction spiro

Publications (1)

Publication Number Publication Date
HK1049157A1 true HK1049157A1 (zh) 2003-05-02

Family

ID=16789385

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03100716.0A HK1049157A1 (zh) 1999-06-30 2003-01-28 具有螺接的三環化合物

Country Status (21)

Country Link
EP (1) EP1191028B1 (zh)
JP (1) JP4890707B2 (zh)
KR (1) KR20020015061A (zh)
CN (1) CN1371375A (zh)
AT (1) ATE281457T1 (zh)
AU (1) AU774397B2 (zh)
BR (1) BR0012093A (zh)
CA (1) CA2380852C (zh)
CZ (1) CZ20014696A3 (zh)
DE (1) DE60015541T2 (zh)
HK (1) HK1049157A1 (zh)
HU (1) HUP0202188A3 (zh)
IL (1) IL147348A0 (zh)
MX (1) MXPA02000003A (zh)
NO (1) NO20016402L (zh)
NZ (1) NZ516363A (zh)
PL (1) PL352862A1 (zh)
SK (1) SK19292001A3 (zh)
TR (1) TR200103853T2 (zh)
WO (1) WO2001002397A1 (zh)
ZA (1) ZA200110558B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2416384A1 (en) * 2000-07-17 2003-01-16 Takeda Chemical Industries, Ltd. Sulfone derivatives, their production and use
EP1346994A4 (en) * 2000-12-28 2005-01-19 Mochida Pharm Co Ltd INHIBITORS OF THE CHOLESTEROL BIOSYNTHESIS CONTAINING TRICYCLIC SPIRO COMPOUNDS AS AN ACTIVE SUBSTANCE
CN100513398C (zh) 2002-12-03 2009-07-15 Axys药物公司 作为因子viia抑制剂的2-(2-羟基联苯-3-基)-1h-苯并咪唑-5-甲脒衍生物
TWI396686B (zh) 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
WO2006006490A1 (ja) * 2004-07-08 2006-01-19 Ono Pharmaceutical Co., Ltd. スピロ化合物
CA2602025A1 (en) 2005-03-31 2006-10-12 Mochida Pharmaceutical Co., Ltd. Tricyclic spiro compound comprising acyl group bound to nitrogen atom in the ring
EP2020411A4 (en) 2006-05-23 2010-08-04 Mochida Pharm Co Ltd TETRACYCLIC SPIRO COMPOUND
US7739434B2 (en) 2008-01-11 2010-06-15 International Business Machines Corporation Performing a configuration virtual topology change and instruction therefore

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3855147D1 (de) * 1987-07-20 1996-05-02 Duphar Int Res 8,9-Anellierte 1,2,3,4-Tetrahydro-beta-carbolin-Derivate
US5292747A (en) * 1990-08-07 1994-03-08 Hoffman-La Roche Inc. Substituted pyrroles

Also Published As

Publication number Publication date
DE60015541T2 (de) 2005-12-08
AU5572000A (en) 2001-01-22
HUP0202188A2 (en) 2002-10-28
CZ20014696A3 (cs) 2002-05-15
HUP0202188A3 (en) 2004-04-28
NZ516363A (en) 2004-05-28
NO20016402L (no) 2002-02-27
EP1191028A4 (en) 2002-10-23
KR20020015061A (ko) 2002-02-27
WO2001002397A1 (fr) 2001-01-11
IL147348A0 (en) 2002-08-14
AU774397B2 (en) 2004-06-24
BR0012093A (pt) 2002-07-16
CN1371375A (zh) 2002-09-25
CA2380852C (en) 2009-10-20
ZA200110558B (en) 2002-09-12
CA2380852A1 (en) 2001-01-11
JP4890707B2 (ja) 2012-03-07
EP1191028B1 (en) 2004-11-03
DE60015541D1 (de) 2004-12-09
MXPA02000003A (es) 2003-07-21
ATE281457T1 (de) 2004-11-15
SK19292001A3 (sk) 2002-06-04
PL352862A1 (en) 2003-09-08
EP1191028A1 (en) 2002-03-27
TR200103853T2 (tr) 2002-11-21
NO20016402D0 (no) 2001-12-28
WO2001002397A9 (fr) 2001-04-05

Similar Documents

Publication Publication Date Title
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
DE69615674T2 (de) Cyclobutan-derivate als inhibitoren der squalen-synthase und der protein farnesyltransferase
EA200800485A1 (ru) Макроциклические ингибиторы вируса гепатита с
ATE540928T1 (de) Isochinolinverbindungen und ihre medizinische verwendung
WO2000061568A3 (de) Mit zuckerresten substituierte 1,4-benzothiazepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
ATE453393T1 (de) Verwendung von pyridylamiden als angiogenesehemmer
AU2001232287A1 (en) Novel pyrazine derivatives or salts thereof, pharmaceutical compositions containing the derivatives or the salts and intermediates for the preparation of both
BR0314688A (pt) Novos derivados de piperidina para utilização no tratamento de estados de doença mediados pela quimiocina
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
DE60226764D1 (de) Substituierte heteroarylalkansäure und ihre verwendung als inhibitoren der aldose reductase
MY139461A (en) Condensed furan compounds
AU6518998A (en) Morphinane derivatives and medicinal use thereof
WO2005005389A3 (en) Malonamide derivatives
IL147348A0 (en) Tricyclic compounds having spiro union
DE60122555D1 (de) Spiroverbindungen und diese als wirkstoff enthaltende adhäsionsmolekülinhibitoren
EP1630160A4 (en) ISOFLAVONIC TECTORIDINE DERIVATIVES, PREPARATION OF THESE DERIVATIVES AND ANTIVIRAL DRUGS CONTAINING THESE DERIVATIVES AS EFFECTIVE INGREDIENTS
WO2003082192A3 (en) Certain pharmaceutically useful substituted aminoalkyl heterocycles
EP1329450A4 (en) BENZODIAZEPINE DERIVATIVE
HK1064673A1 (en) Fused-polycyclic compounds
AU2002339158A1 (en) 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
DK1072601T3 (da) 4-Arylpiperidinderivater til behandling af pruritus
TH80960B (th) ซัลฟานิลแทนที่ฟีนิลเมทธาโนนซ์
TH80960A (th) ซัลฟานิลแทนที่ฟีนิลเมทธาโนนซ์